Antineoplastic effects of Ankaferd hemostat

UY Malkan, IC Haznedaroglu - BioMed research international, 2022 - Wiley Online Library
Objectıve. Ankaferd hemostat (ABS; Ankaferd Blood Stopper®) contains standardized plant
extracts comprising Alpinia officinarum, Glycyrrhiza glabra, Thymus vulgaris, Urtica dioica …

Ankaferd hemostat: from molecules to medicine

R Ciftciler, IC Haznedaroğlu - Turkish Journal of Medical …, 2020 - journals.tubitak.gov.tr
Abstract Ankaferd hemostat (ABS; Ankaferd Blood Stopper®, İstanbul, Turkey) is a
hemostatic agent having an impact on red blood cell-fibrinogen interactions. The hemostatic …

Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines

S Turk, UY Malkan, M Ghasemi… - SAGE open …, 2017 - journals.sagepub.com
Objective: Ankaferd hemostat is the first topical hemostatic agent about the red blood cell–
fibrinogen relations tested in the clinical trials. Ankaferd hemostat consists of standardized …

Ankaferd Blood Stopper induces apoptosis and regulates PAR1 and EPCR expression in human leukemia cells

M Mumcuoglu, DF Akin, U Ezer, N Akar - Egyptian Journal of Medical …, 2015 - ajol.info
Background: Ankaferd Blood Stopper (ABS) is a preparation of plant extracts originally used
as a hemostatic agent. It has pleiotropic effects in many cellular processes such as cell cycle …

Qualitative/chemical analyses of Ankaferd hemostat and its antioxidant content in synthetic gastric fluids

A Koluman, N Akar, UY Malkan… - BioMed research …, 2016 - Wiley Online Library
Introduction. Ankaferd hemostat (ABS) is the first topical haemostatic agent involving the red
blood cell‐fibrinogen interactions. The antihemorrhagic efficacy of ABS has been tested in …

Effects of Ankaferd on anastomotic healing of colon

G Cancan, S Teksoz, E Aytac, AE Arikan… - Journal of …, 2014 - Taylor & Francis
ABSTRACT Background: Ankaferd (Ankaferd blood stopper®, ABS) is a recently developed
topical hemostatic agent. ABS is a standardized mixture of the plants Thymus vulgaris …

Acute in vitro effects of ABS (Ankaferd Hemostat) on the lymphoid neoplastic cells (B-CLL and RAJI tumor cell lines)

I Akalin, F Okur, İ HAZNEDAROĞLU… - Uhod-Uluslararasi …, 2014 - avesis.hacettepe.edu.tr
ABS (Ankaferd Hemostat) has emerged as a novel haemostatic agent of plant origin. Its
ability to interact with entire proteins including cell surface receptors and/or blood proteins …

[PDF][PDF] Safety and Efficacy of Ankaferd Hemostat (ABS) in the Chemotherapy-Induced Oral Mucositis.

MH Atay, NA ASLAN, S Aktimur… - … of Hematology & …, 2015 - researchgate.net
Oral mucositis, characterized by ulcerative lesions in the oral mucosa of patients undergoing
chemotherapy, is currently considered to be the most severe complication of anti-cancer …

Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper)

R Ciftciler, AE Ciftciler, UY Malkan… - SAGE Open …, 2020 - journals.sagepub.com
Ankaferd hemostat (Ankaferd blood stopper [ABS], Istanbul, Turkey) is a hemostatic agent
affecting red blood cell-fibrinogen interactions. ABS has been traditionally used in Anatolia …

[PDF][PDF] Ankaferd hemostat induces DNA damage, apoptosis and cytotoxic activity by generating reactive oxygen species in melanoma and normal cell lines

A Kocyigit, EM Guler, IC Haznedaroglu… - International Journal of …, 2017 - e-century.us
Although, Ankaferd hemostat (Ankaferd Blood Stopper, ABS) could be utilized successfully
as hemostatic agent, studies demonstrated that it has cytotoxic effects on cells. However, the …